Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice

Main Article Content

Giorgio Ciprandi
Maria Angela Tosca
Irene Schiavetti
Roberta Olcese
Michele Miraglia del Giudice


Asthma, Children, FEF25-75


Background Reversible bronchial obstruction characterizes asthma. Spirometry is the gold standard to assess airflow, and FEV1 is the most reliable parameter in this regard. However, many children with asthma have FEV1 within the normal range despite uncontrolled asthma and worsening. Therefore, FEF25-75 has been proposed as a valuable marker of early airflow impairment. This study aimed at investigating FEF25-75 in a cohort of children with newly diagnosed asthma.

Methods 381 children (122 females, mean age 11.6 years) were consecutively visited and had a new asthma diagnosis. In addition, Spirometry, type-2 phenotyping, asthma control assessment, and ACT were performed.

Results 72 (18.9%) asthmatic children had impaired FEF25-75, such as <65% of predicted. Low FEF25-75 was associated with lower FVC and FEV1/FVC values (OR 1.11 and 1.32, respectively). Children with normal FEV1 but impaired FEF25-75 had more frequently uncontrolled asthma (15.8% vs. 32.4%) than children with both parameters within the normal range.

Conclusions FEF25-75 deserves adequate and careful consideration in children with asthma, and the presence of impaired FEF25-75 values suggests a more compelling approach.



Download data is not yet available.
Abstract 33 | PDF Downloads 25


1) Tosca MA, Schiavetti I, Duse M, Marseglia GL, Ciprandi G. A survey on the management of children with asthma in primary care setting in Italy. Ped Allergy Immunol Pulmonol 2021;34:39-42
2) Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, et al. “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J 2019;53:1800938
3) Global Initiative for Asthma. GINA guidelines. Global strategy for Asthma Management and Prevention. 2021. Available at: htpp:// Accessed on October 2021
4) Gaillard EA, Kuehni CE, Turner S, Goutaki M, Holden KA, de Jong CCM, et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years. Eur Respir J 2021:2004173
5) Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, et al. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. European Respiratory Journal 2021;57:2000289
6) Bush A. Lung Development and Aging. Ann Am Thorac Soc. 2016;Suppl 5:S438-S446
7) Simon MR, Chinchilli VM, Phillips BR, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010;126:527-34
8) Siroux V, Boudier A, Dolgopoloff M, Chanoine S, Bousquet J, Gormand F, et al. Forced midexpiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes. J Allergy Clin Immunol 2016;137:1709-16
9) Ciprandi G, Cirillo I. The pragmatic role of FEF(25-75) in asymptomatic subjects, allergic rhinitis, asthma, and in military setting. Expert Rev Respir Med. 2019;13(12):1147-1151
10) Kwon DS, Choi YJ, Kim TH, Byun MK, Cho JH, Kim HJ, et al. FEF(25-75%) Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2913-2921
11) Qin R, An J, Xie J, Huang R, Xie Y, He L, et al. FEF(25-75)% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF(25-75)% and FEV(1). J Allergy Clin Immunol Pract 2021;9(10):3649-3659.e6
12) Kong JK, Lee SH, Jung JY, Eom SY, Hahn YS. Clinical implications of the FEF(25-75) variability in childhood asthma. Ann Allergy Asthma Immunol. 2018;121(4):496-497
13) Liu X, Wang X, Yao X, Wang Y, Sun Y, Zhang L. Value of Exhaled Nitric Oxide and FEF(25-75) in Identifying Factors Associated With Chronic Cough in Allergic Rhinitis. Allergy Asthma Immunol Res. 2019;11(6):830-845
14) Szefler SJ, Goldstein S, Vogelberg C, Bensch GW, Given J, Jugovic B, et al. Forced Expiratory Flow (FEF(25-75%)) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis. Pulm Ther. 2020;6(2):151-158
15) Tosca MA, Marseglia GL, Ciprandi G; “ControL’Asma” Study Group. The real-world "ControL'Asma" study: a nationwide taskforce on asthma control in children and adolescents. Allergol Immunopathol (Madr). 2021;49(1):32-39
16) Ciprandi G, Gallo F, Cirillo I. FEF25-75 and Asthma in Clinical Practice. Iran J Allergy Asthma Immunol. 2018;17(3):295-297
17) Thomson NC, Chaudhuri R, Spears M, Messow CM, MacNee W, Connell M, et al. Poor symptom control is associated with reduced CT scan segmental airway lumen area in smokers with asthma. Chest. 2015;147:735-44
18) Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, Tosca MA, et al. Role of FEF25-75 as predictor of bronchial hyperreactivity in allergic patients. Annals Allergy Asthma Immunology 2006;96:692-700
19) Ciprandi G, Capasso M, Leonardi S, Lionetti E, La Rosa M, Salpietro C, et al. Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma. J Bio Regulator 2012;26:19-26
20) Ciprandi G, Tosca MA, Cirillo I, Lionetti E, Leonardi S, Miraglia del Giudice M, et al. Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma. J Bio Regulator 2012;26:27-3

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>